Reprint This Article

The answer may lie in how pharmaceutical companies are targeting their R&D spending.
Efraim Benmelech, Janice C. Eberly, Joshua Krieger and Dimitris Papanikolaou
If you are interested in reprinting this article, please contact us for permission, guidelines, code, and a canonical link. There is no fee for reprinting an article.
© Kellogg School of Management, Northwestern
University. All Rights Reserved. Privacy Policy.
University. All Rights Reserved. Privacy Policy.